University Lab Partners (ULP) announced NovoThelium as the winner of the 2nd annual Golden Ticket Pitch Competition for aesthetic startups, sponsored by Allergan Aesthetics, an AbbVie company.

This year, five finalists were selected to present their innovative aesthetic technologies to an expert panel of judges, including Charlie Hee, Ph.D., Vice President, Devices, Aesthetics R&D at Allergan Aesthetics; Sherly Soleiman, M.D., Founder, Owner and Lead Injector at Cosmetic Injectable Center; and Michael Hill, Managing Director, Capital Markets at Octane.

"Winning the Golden Ticket from University Lab Partners and Allergan Aesthetics will provide NovoThelium with vital resources and mentorship, enabling us to enhance women's healthcare and pioneer innovations in nipple reconstruction post-mastectomy," said Lauren Cornell, PhD, Co-Founder and CEO of NovoThelium.

Read more at PR Newswire >>